Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Mr. Deepak Nath es el Chief Executive Officer de Smith & Nephew plc, se unió a la empresa desde 2022.
¿Qué tal es el rendimiento del precio de la acción Smith & Nephew SNATS, Inc.?
El precio actual de Smith & Nephew SNATS, Inc. es de $32.16, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Smith & Nephew plc?
Smith & Nephew plc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Smith & Nephew plc?
La capitalización bursátil actual de Smith & Nephew plc es $13.6B
¿Es Smith & Nephew plc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 19 analistas han realizado calificaciones de análisis para Smith & Nephew plc, incluyendo 6 fuerte compra, 8 compra, 9 mantener, 0 venta, y 6 fuerte venta